STORM in the News
BioCentury: Playing in RNA
Virginia Li talks to Hakan Goker, M Ventures about STORM Therapeutics and investing in RNA
https://www.biocentury.com/biocentury/finance/2018-11-13/why-m-ventures-led-30m-series-rna-company-ribometrix?kwh=therapeutics%3C